• 목록
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medications during breastfeeding and pregnancy is a challenge for women suffering from the condition. There is a lack of information about how long-term exposure to these medications could affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus do not develop neurological disorders like impaired vision or hearing seizures, febrile seizures or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication need to weigh the benefits of taking it against the potential risks for the foetus. Physicians don't have the necessary data to give clear guidelines however they can provide information on risks and benefits that help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who were taking ADHD medications in early pregnancy did not have an higher risk of fetal cardiac malformations or major structural birth defects. The researchers used a large population-based study of case-control to evaluate the incidence of major structural birth defects in babies born to mothers who had taken stimulants during early pregnancy, as well as those who had not. Pediatric cardiologists, clinical geneticists and other experts looked over the cases to make sure that the classification was correct and to eliminate any bias.

The study conducted by the researchers had some limitations. Most important, they were unable to separate the effects of the medication from the disorder that is underlying. This limitation makes it difficult for researchers to determine whether the few associations observed between the groups exposed were due to the use of medication, or if they were affected by co-morbidities. Researchers also did not examine the long-term effects for the offspring.

The study revealed that infants whose mothers took ADHD medication during pregnancy were at a slightly higher risk of admission to the neonatal care unit (NICU), compared to those whose mothers didn't take any medication during pregnancy or discontinued taking their medication prior to or during pregnancy. This increase was caused by central nervous system disorders. The increased risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having a caesarean section or a baby that scored low on the Apgar scale (less than 7). These increases appeared to be unrelated to the type of medication taken during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during early pregnancy could be offset by the higher benefit to both mother and child of continuing treatment for the woman's disorder. Physicians should discuss the issue with their patients and, if possible, assist them in developing strategies to improve coping skills that can lessen the negative impact of her condition on her daily life and relationships.

Interactions with Medication

As more women than ever are being diagnosed with ADHD and treated with medication, the dilemma of whether to continue or discontinue treatment during pregnancy is one that doctors are having to confront. Often, these decisions are made in the absence of any evidence that is clear and definitive in either case, which means that doctors must weigh what they know from their own experiences, those of other doctors, and what research suggests about the subject as well as their Best Non Stimulant Adhd Medication For Adults judgment for each patient.

The issue of potential risks to the infant can be extremely difficult. Many studies on this topic are based on observations rather than controlled research and their findings are often contradictory. Most studies focus on live births, which can underestimate the severity of teratogenic effects leading to terminations or abortions of pregnancy. The study presented in this journal club addresses these shortcomings by analyzing data on live and deceased births.

The conclusion The conclusion: While certain studies have demonstrated that there is a positive correlation between ADHD medications and the risk of certain birth defects, other studies have found no connection, and most studies have a neutral or slightly negative impact. In every case, a careful evaluation of the risks and benefits should be conducted.

It isn't easy, but not impossible, for women suffering from ADHD to stop taking their medication. In a recent piece published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of loneliness. In addition, a decrease in medication can interfere with the ability to do work-related tasks and safely drive, which are important aspects of a normal life for many people suffering from ADHD.

She suggests that women who are unsure about whether or not to discontinue medication due to their pregnancy, consider educating family members, friends and colleagues about the condition, its effects on daily functioning, and the advantages of continuing the current treatment plan. Educating them can also aid in ensuring that the woman feels supported as she struggles with her decision. It is important to note that some drugs can pass through the placenta so if a woman decides to stop her ADHD medication during pregnancy and breastfeeding, she must be aware that traces of the drug could be transferred to the infant.

Risk of Birth Defects

As the use and misuse of ADHD medications to treat the symptoms of attention deficit hyperactivity disorder (ADHD), increases, so does concern about the potential effects of these drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this topic. Utilizing two huge data sets researchers were able analyze more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. Researchers discovered that although the risk overall is low, first-trimester ADHD exposure to medication was associated with slightly higher rates of certain heart defects, like ventriculoseptal defect.

The researchers of the study found no connection between early use of medication for adhd and anxiety in adults and congenital abnormalities such as facial clefting or club foot. The results are in line with previous studies showing an increase, but not significant, in the risk of cardiac malformations in women who started taking ADHD medications prior to the time of the time of pregnancy. The risk was higher in the latter half of pregnancy, when a lot of women begin to discontinue their ADHD medication.

Women who used ADHD medications during the first trimester of pregnancy were also more likely to experience caesarean section, low Apgar score after delivery and a baby who required help breathing at birth. However the researchers of the study were unable to eliminate bias due to selection by restricting the study to women who did not have any other medical conditions that could have contributed to these findings.

Researchers hope that their study will inform physicians when they meet pregnant women. The researchers recommend that while discussing the risks and benefits are crucial, the decision regarding whether or not to stop medication should be made based on the severity of each woman's ADHD symptoms and the needs of the woman.

The authors also caution that while discontinuing the medications is an option, it is not a recommended practice because of the high rate of depression and other mental health problems for women who are expecting or postpartum. Additionally, the research suggests that women who choose to stop their medications are more likely to have a difficult time adapting to life without them after the baby's arrival.

Nursing

The responsibilities that come with being a new mother can be overwhelming. Women with ADHD are often faced with a number of difficulties when they have to manage their symptoms, go to doctor appointments and prepare for the birth of their child and adjust to a new routine. As such, many women choose to continue taking their ADHD medications throughout pregnancy.

The majority of stimulant medicines are absorbed by breast milk in very small amounts, therefore the risk to the breastfeeding infant is minimal. However, the frequency of medication exposure to the newborn may differ based on dosage, frequency it is administered, and the time of the day the medication is administered. In addition, various drugs enter the infant's system via the gastrointestinal tract, or through breast milk. The effect on the health of a newborn isn't fully understood.

Some doctors may decide to stop stimulant medications during a woman's pregnancy due to the absence of research. It's a difficult choice for the woman, who must weigh the advantages of her medication against the potential risks to the foetus. As long as more information is available, GPs can you get adhd medication without a diagnosis inquire about pregnant patients if they have an background of ADHD or if they intend to take medication during the perinatal period.

A increasing number of studies have shown that most women can safely continue taking their ADHD medication while they are pregnant and nursing. In the end, more and more patients are choosing to do so and, after consulting with their doctor, they have discovered that the benefits of continuing their current medication outweigh any risks.

Women who suffer from common adhd medications uk who are planning to breastfeed should seek advice from a specialist psychiatrist before becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continued treatment, including non-pharmacological management strategies. Psychoeducation is also needed to help pregnant women suffering from ADHD recognize the signs and underlying disorder. They should also learn about treatment options and reinforce the coping mechanisms. This should include a multidisciplinary approach with the GP, obstetricians and psychiatry. Pregnancy counselling should include discussion of a management plan for both the mother and child, as well as monitoring for signs of deterioration and the need for adjustments to the medication regimen.